The Dominance of Hormone Receptor-Positive Disease and Endocrine Therapy Resistance
Given that approximately 90% of male breast cancers are driven by estrogen receptors, endocrine therapy remains the foundational pillar of systemic treatment, particularly Tamoxifen. However, as the disease progresses, patients inevitably develop resistance to first-line agents, necessitating a pipeline of...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
